Perfusion CT and perfusion MRI - A new tool in diagnostics of intracranial tumours;Badania perfuzyjne TK i MR - Nowe narzedzie w diagnostyce guzów wewnatrzczaszkowych

Advances in Clinical and Experimental Medicine

Volumn 14, Issue 3, 2005, Pages 583-592

  Zimny, Anna ^a   Sasiadek, Marek ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Angiogenesis; Intracranial tumours; Perfusion CT; Perfusion MRI

Indexed keywords

ARTICLE; BRAIN BIOPSY; BRAIN ISCHEMIA; BRAIN METASTASIS; BRAIN MICROCIRCULATION; BRAIN PERFUSION; BRAIN REGION; BRAIN TOMOGRAPHY; BRAIN TUMOR; CANCER GRADING; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; IN VIVO STUDY; INTRACRANIAL TUMOR; MEDICAL LITERATURE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; STEREOTAXIC SURGERY; TUMOR NECROSIS; TUMOR RECURRENCE; TUMOR VASCULARIZATION;

EID: 21644484374     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Pilch-Kowalczyk J, Konopka M, Gibińska J, Hartel M: Perfuzja TK - nowa jakość w diagnostyce obrazowej udaru niedokrwiennego. Med Sci Rev 2002, 1, 62-66.
2. Aksoy FG, Lev MH: Dynamic Contrast-Enhanced Brain Perfusion Imaging: Technique and Clinical Applications. Sem Ultrasound CT MRI 2000, 21 (6), 462-477.
3. Rosenberger R, Wojtek P, Konopka M, Pieniazek P, Bogusz I, Sasiadek M: Kliniczne zastosowanie obrazowania perfuzyjnego tomografii komputerowej oraz obrazowania dyfuzyjnego i perfuzyjnego rezonansu magnetycznego w wykrywaniu wczesnych zmian w udarze niedokrwiennym moźgu. Udar Mózgu 2004, 6 (2), 71-78.
4. Folkman J: The role of angiogenesis in tumor growth. Semin Cancer Biol 1992, 3, 65-71.
5. Brem S, Cotran R, Folkman J: Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst 1972, 48, 347-356.
6. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990, 82, 4-6.
7. Burger P: Malignant astrocytic neoplasms: classification, pathology, anatomy, and response to therapy. Semin Oncol 1986, 13, 16-20.
8. Fulling K, Garcia D: Anaplastic astrocytoma of the adult cerebrum; prognostic value of histologic features. Cancer 1985, 55, 928-931.
9. Fulling KH, Garcia DM: Anaplastic astrocytoma of the adult cerebrum: prognostic value of histologic features. Cancer 1985, 55, 928-931.
10. Wintermark M, Maeder P, Thiran JP, Schnyder P, Meuli R: Quantitative assessment of regional cerebral blood flows by perfusion CT studies at low injection rates: a critical review of the underlying theoretical models. Eur Radiol 2001, 11, 1220-1230.
11. Alsop DC, Detre JA: Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology 1998, 208, 410-416.
12. Lev MH, Hochberg F: Perfusion Magnetic Resonance Imaging to Assess Brain Tumor Responses to New Therapies. Cancer Control 1998, 5 (2), 115-123.
13. Roberts HC, Roberts TPL, Lee TY, Dillon WP: Dynamic, Contrast-Enhanced CT of Human Brain Tumors: Quantitative Assessment of Blood Volume, Blood Flow, and Microvascular Permeability: Report of Two Cases. Am J Neuroradiol 2002, 23, 828-832.
14. Provenzale JM, Wang GR, Brenner T, Petrella JR, Sorensen AG: Comparison of Permeability in High-Grade and Low-Grade Brain Tumors Using Dynamic Susceptibility Contrast MR Imaging. Am J Roentgenol 2002, 178, 711-716.
15. Johnson PC, Hunt SJ, Drayer BP: Human cerebral gliomas: correlation of postmortem MR imaging and neuropathologic findings. Radiology 1989, 170, 211-217.
16. Chamberlain MC, Murovic JA, Levin VA: Absence of contrast enhancement of CT brain scans of patients with supratentorial malignant gliomas. Neurology 1988, 38, 1371-1374.
17. Barker FG 2nd, Chang SM, Huhn SL, Davis RL, Gutin PH, McDermott WM, Wilson CB, Prados MC: Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 1997, 80, 936-941.
18. Ginsberg L, Fuller G, Schomer D, Kau BA, Kispert DB: Does lack of enhancement of brain tumors on MR imaging correlate with low grade malignancy? A histopathologic study. In: Proceedings of the American Society of Neuroradiology. Seattle-Washington 1996, 32-33.
19. Coffey R, Lunsford LD, Taylor FH: Survival after stereotactic biopsy of malignant gliomas. Neurosurgery 1988, 22, 465-473.
20. Kelly PJ, Daumas-Duport C, Scheithauer BE: Stereotactic histologic correlations of computed tomography and magnetic resonance imaging defined abnormalities in patients with glial neoplasms. Mayo Clinic Proc 1987, 62, 450-459.
21. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW: High-Grade Gliomas and Solitary metastases: Differentiation by Using Perfusion and Proton Spectroscopic MR Imaging. Radiology 2002, 222, 715-721.
22. Lüdemann L, Grieger W, Wurm R, Budzisch M, Hamm B, Zimmer C: Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas. Eur Radiol 2001, 11, 1231-1241.
23. Knopp EA, Cha S, Johnson G, Mazumdar A, Golfinos JG, Zagzag D, Miller DC, Kelly PJ, Kricheff II: Glial Neoplasms: Dynamic Contrast-Enhanced T2*-weighted MR Imaging. Radiology 1999, 211, 791-798.
24. Principi M, Italiani M, Guiducci A, Aprile I, Muti M, Giulianelli G, Ottoviano P: Perfusion MRI in the evaluation of the relationship between tumour growth, necrosis and angiogenesis in glioblastomas and grade 1 meningiomas. Neuroradiology 2003, 45, 205-211.
25. Kleihaus P, Burger PC, Scheithauer BW: Histological typing of tumours of central nervous system. World Health Organization international histological classification of tumours. Springer-Verlag, Berlin-Heilderberg 1993, 2nd ed., 20-96.
26. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Griffith RH, Cosgrove GR, Halpern EF, Hochberg FH, Rosen BR: Cerebral Blood Volume Maps of Gliomas: Comparison with Tumor Grade and Histologic Findings. Radiology 1994, 191, 41-51.
27. Roberts HC, Roberts TPL, Brasch RC, Dillon WP: Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. Am J Neuroradiol 2000, 21, 891-899.
28. Sugahara T, Korogi Y, Kochi M, Ikushima I, Hirai T, Okuda T, Shigematsu Y, Liang L, Ge Y, Ushio Y, Takahashi M: Correlation of MR Imaging-Determinated Cerebral Blood Maps with Histologic and Angiographic Determination of Vascularity of Gliomas. Am J Roengenol 1998, 171, 1479-1486.
29. Aronen HJ, Glass J, Pardo FS, Bellieveau JW, Gruber ML, Buchbinder BR, Gozit IE, Lingood RM, Fischman AJ, Rosen BR: Echo-planar MR cerebral blood volume mapping of gliomas: clinical utility. Acta Radiol 1995, 36, 520-528.
30. Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D: The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. J Neurosurg 1992, 76, 741-745.
31. Eastwood JD, Provenzale JM: Cerebral flow, blood volume, and vascular permeability of cerebral glioma assessed with dynamic CT perfusion imaging. Neuroradiology 2003, 45, 373-376.
32. Nabavi DG, Cenic A, Craen RA, Gello AW, Bennett JD, Kozak R, Lee TY: CT assessment of cerebral perfusion: experimental validation and initial clinical experience. Radiology 1999, 213, 141-149.
33. Bruening R, Wu R, Yousry T: Regional cerebral blood volume maps of meningiomas before and after partial embolization. In: American Society of Neuroradiology, Seattle-Washington 1996, 153.
34. Ernst T, Chang L, Witt M: Cerebral toxoplasmosis and lymphoma in AIDS: Perfusion MR imaging experience in 13 patients. Radiology 1998, 208, 663-669.
35. Lev MH, Schaefer PW, Barest GD: Radiation necrosis or glioma recurrence? Magnetic resonance relative cerebral blood volume imaging in proton beam treated patients. In: Proceedings of the 83rd Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago 1997.
36. Siegal T, Rubinstein RI, Tzuk-Shina T Gomori JM: Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors. J Neurosurg 1997, 86, 22-27.
37. Østergaard L, Hochberg FH, Rabinov JD, Sorensen AG, Lev M, Kim L, Weisskoff RM, Gonzalez RG, Gyldensted C, Rosen BR: Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg 1999, 90, 300-305.
38. Hossman KA, Bloink M: Blood flow and regulation of blood flow in experimental peritumoral edema. Stroke 1981, 12, 211-217.